Amarin Corp Plc (AMRN)

[Whalatane]

https://thehill.com/opinion/healthcare/369727-us-drug-prices-higher-than-in-the-rest-of-the-world-heres-why

Most of the valuations for the EU market that I've seen on this board ....are IMHO ignoring the basic reality that AMRN will make far less selling a bottle of Vascepa in the EU than it does in the US .

Most of the healthcare in the EU has some degree of govt control and like poster Pharmadude has explained to you re the Canadian market ......will want tp pay roughly 45% less than what AMRN is charging as WAC ( wholesale acquisition costs ) in the US .

The EU is also a very fragmented market and in some countries like Poland ( 45m ? people ) there will probably be no govt subsidy for Vascepa and few there will be willing to pay out of pocket full retail cost.

Suggest you all ( or most of you ) lower your expectations for how the EU will roll out

Kiwi